- Home
- Publications
- Publication Search
- Publication Details
Title
Insulin discovery: A pivotal point in medical history
Authors
Keywords
Diabetes, Insulin discovery, Insulin therapy, Insulin analogs, Glucose-responsive insulin, Insulin administration routes
Journal
METABOLISM-CLINICAL AND EXPERIMENTAL
Volume 127, Issue -, Pages 154941
Publisher
Elsevier BV
Online
2021-11-25
DOI
10.1016/j.metabol.2021.154941
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- New closed-loop insulin systems
- (2021) Charlotte K. Boughton et al. DIABETOLOGIA
- ‘Smart’ insulin-delivery technologies and intrinsic glucose-responsive insulin analogues
- (2021) Mark A. Jarosinski et al. DIABETOLOGIA
- Molecular Engineering of Insulin Icodec, the First Acylated Insulin Analog for Once-Weekly Administration in Humans
- (2021) Thomas B. Kjeldsen et al. JOURNAL OF MEDICINAL CHEMISTRY
- 99-LB: A Phase 2b Study of Oral Insulin (Capsulin) Administered to Patients with Type 2 Diabetes
- (2021) ROGER R.C. NEW et al. DIABETES
- Efficacy and safety of 28‐day treatment with oral insulin ( ORMD ‐0801) in patients with type 2 diabetes: A randomized, placebo‐controlled trial
- (2021) Roy Eldor et al. DIABETES OBESITY & METABOLISM
- One Hundred Years of Insulin for Some
- (2021) Amy Moran-Thomas NEW ENGLAND JOURNAL OF MEDICINE
- Insulin action at a molecular level – 100 years of progress
- (2021) Morris F. White et al. Molecular Metabolism
- A fully implantable device for intraperitoneal drug delivery refilled by ingestible capsules
- (2021) Veronica Iacovacci et al. Science Robotics
- Artificial intelligence and diabetes technology: A review
- (2021) Thibault Gautier et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The continuing quest for better subcutaneously administered prandial insulins: a review of recent developments and potential clinical implications
- (2020) David R. Owens et al. DIABETES OBESITY & METABOLISM
- Time for a paradigm shift in treating type 1 diabetes mellitus: coupling inflammation to islet regeneration
- (2020) Nadia Cobo-Vuilleumier et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Precision medicine in diabetes: a Consensus Report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
- (2020) Wendy K. Chung et al. DIABETOLOGIA
- New and Emerging Technologies in Type 1 Diabetes
- (2020) Jordan S. Sherwood et al. ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA
- Once-Weekly Insulin for Type 2 Diabetes without Previous Insulin Treatment
- (2020) Julio Rosenstock et al. NEW ENGLAND JOURNAL OF MEDICINE
- Precision medicine in the era of artificial intelligence: implications in chronic disease management
- (2020) Murugan Subramanian et al. Journal of Translational Medicine
- Efficacy and safety of oral basal insulin versus subcutaneous insulin glargine in type 2 diabetes: a randomised, double-blind, phase 2 trial
- (2019) Inge B Halberg et al. Lancet Diabetes & Endocrinology
- An ingestible self-orienting system for oral delivery of macromolecules
- (2019) Alex Abramson et al. SCIENCE
- Elucidating the Mechanism of Absorption of Fast-Acting Insulin Aspart: The Role of Niacinamide
- (2019) Jonas Kildegaard et al. PHARMACEUTICAL RESEARCH
- Oral Drug Delivery Technologies-A Decade of Developments
- (2019) Gagandeep K Kaur et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Insulin Therapy
- (2019) Simona Cernea et al. AMERICAN JOURNAL OF THERAPEUTICS
- Pharmacotherapy of type 2 diabetes: An update
- (2018) Jagriti Upadhyay et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Aretaeus of Cappadocia and the first description of diabetes
- (2018) Konstantinos Laios et al. Hormones-International Journal of Endocrinology and Metabolism
- BioChaperone Lispro versus faster aspart and insulin aspart in patients with type 1 diabetes using continuous subcutaneous insulin infusion: A randomized euglycemic clamp study
- (2018) Tim Heise et al. DIABETES OBESITY & METABOLISM
- Stem cells in the treatment of diabetes mellitus — Focus on mesenchymal stem cells
- (2018) Günter Päth et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Development of glucose-responsive ‘smart’ insulin systems
- (2017) Nischay K. Rege et al. Current Opinion in Endocrinology Diabetes and Obesity
- Current status of selected oral peptide technologies in advanced preclinical development and in clinical trials
- (2016) T.A.S. Aguirre et al. ADVANCED DRUG DELIVERY REVIEWS
- Pharmacokinetic and Pharmacodynamic Properties of Faster-Acting Insulin Aspart versus Insulin Aspart Across a Clinically Relevant Dose Range in Subjects with Type 1 Diabetes Mellitus
- (2016) Tim Heise et al. CLINICAL PHARMACOKINETICS
- Pharmacokinetics and pharmacodynamics of insulin glargine 300 U/mL in the treatment of diabetes and their clinical relevance
- (2016) David R. Owens Expert Opinion on Drug Metabolism & Toxicology
- Immune therapy in type 1 diabetes mellitus — Attempts to untie the Gordian knot?
- (2016) Nikolaos Perakakis et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?
- (2015) P. D. Home DIABETES OBESITY & METABOLISM
- Insulin Aspart in the Management of Diabetes Mellitus: 15 Years of Clinical Experience
- (2015) Kjeld Hermansen et al. DRUGS
- AFREZZA® (insulin human) Inhalation Powder: A Review in Diabetes Mellitus
- (2015) Esther S. Kim et al. DRUGS
- Microneedle-array patches loaded with hypoxia-sensitive vesicles provide fast glucose-responsive insulin delivery
- (2015) Jicheng Yu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- New forms of insulin and insulin therapies for the treatment of type 2 diabetes
- (2015) Avivit Cahn et al. Lancet Diabetes & Endocrinology
- Insulin Degludec: A Novel Basal Insulin Analogue
- (2013) Jennifer D Goldman-Levine et al. ANNALS OF PHARMACOTHERAPY
- Fc-fusion proteins and FcRn: structural insights for longer-lasting and more effective therapeutics
- (2013) Timo Rath et al. CRITICAL REVIEWS IN BIOTECHNOLOGY
- Insulin degludec improves glycaemic control with lower nocturnal hypoglycaemia risk than insulin glargine in basal-bolus treatment with mealtime insulin aspart in Type 1 diabetes (BEGIN®Basal-Bolus Type 1): 2-year results of a randomized clinical trial
- (2013) B. W. Bode et al. DIABETIC MEDICINE
- Efficacy and Safety of Insulin Degludec in a Flexible Dosing Regimen vs Insulin Glargine in Patients With Type 1 Diabetes (BEGIN: Flex T1): A 26-Week Randomized, Treat-to-Target Trial With a 26-Week Extension
- (2013) Chantal Mathieu et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future
- (2013) Steven E Kahn et al. LANCET
- Pharmacokinetics and Pharmacodynamics of Basal Insulins
- (2011) Francesca Porcellati et al. Diabetes Technology & Therapeutics
- Management of type 2 diabetes: new and future developments in treatment
- (2011) Abd A Tahrani et al. LANCET
- Why were "starvation diets" promoted for diabetes in the pre-insulin period?
- (2011) Allan Mazur Nutrition Journal
- The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes
- (2009) S. D. Luzio et al. DIABETES OBESITY & METABOLISM
- Insulin Glulisine
- (2009) Karly P. Garnock-Jones et al. DRUGS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now